All Articles

ICON International's new entertainment arm uses media trade and novel financial models to fund content, creating a new roadmap for brands and creators alike.

Accor's Handwritten Collection just hit 50 hotels, with 50 more coming. Here's the strategic playbook behind its explosive, character-driven growth.

A Chinese city is investing billions to become a global satellite hub, unveiling ambitious plans for carbon monitoring and international partnerships. Is this a tech boom or a new front in space geopolitics?

Cross Timbers Royalty Trust's June distribution reveals a complex narrative of divergent commodity prices, falling volumes, and persistent operational costs.

Century 21 Canada reports a stunning 39% growth surge in Quebec. Is this a fluke, or a new blueprint for challenging market leaders with tech and local focus?

With a fresh $50M, Enhanced Group is selling a future of medically-guided peak performance. But can its controversial Games and peptide platform survive regulatory scrutiny?

Dr. Glenn Parker's recent award is more than a trophy. It's a signal of a quiet revolution in healthcare—one that uses fintech to build national resilience.

Bitdeer reports a 370% surge in Bitcoin mining while aggressively converting its global power grid to support AI, deploying top-tier NVIDIA GPUs.

Nephros is moving from a product company to a service-based model. We unpack the strategy, financial risks, and why this pivot could redefine its market.

As OMS Energy prepares its FY2026 results, its performance offers a unique window into the future of oil & gas in the pivotal Asia-MENA corridor.

Latin American software acquirer Nuvini is betting its future on 100% employee AI adoption, using an internal prize to transform its entire workforce.

Ambow Education launches HybriU ProjectHub, an AI platform aiming to unify a chaotic landscape of apps. But can it break through in a market dominated by titans?

A new patent gives CervoMed a long runway for its dementia drug, but can this IP victory secure the massive funding needed to cross the finish line?

Asimov's AI-driven synthetic biology platform partners with McGill's Goodman Cancer Institute, aiming to break the manufacturing bottleneck for complex drugs.

As air disc brakes become the new standard, DRiV's Abex brand moves beyond parts to offer an integrated system, simplifying maintenance and boosting safety.

A 'dream team' of pharma veterans has raised $180M to advance a next-gen oral drug, promising to transform the multi-billion dollar IBD market.

A massive conditional loan from the Pentagon's investment arm aims to transform a Utah uranium mill into a cornerstone of America's critical minerals strategy.

A new spray-dried plasma could end reliance on freezers, transforming trauma care from the battlefield to rural ERs. But can Velico navigate the path to market?

As Retevis offers military-tested two-way radios on Prime Day, businesses are discovering that true reliability doesn't come from a smartphone.

An investor tour reveals China's stunning sustainable tech, but the real challenge is financial. Can high-tech farms prove they are 'bankable'?